Search research articles
Contact Us
Filters
Showing results (891-900 of 949) with videos related to
Page
of 95
Sort By:
Nature Communications
|
April 17, 2026
NKG2A inhibition promotes NK cell-CD8<sup>+</sup> T cell interactions to improve anticancer immunity in ovarian carcinoma
Tereza Lanickova, Artemis Angelidou, Michal Hensler, et al.
Nature Communications
|
March 22, 2024
Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer
Lenka Kasikova, Jana Rakova, Michal Hensler, et al.
Molecular Cancer Therapeutics
|
September 5, 2025
Advancing preclinical biology for Ewing Sarcoma: an international effort
Filemon S Dela Cruz, Elizabeth A Stewart, Didier Surdez, et al.
BMC Microbiology
|
November 8, 2007
Subtle genetic changes enhance virulence of methicillin resistant and sensitive Staphylococcus aureus
Sarah K Highlander, Kristina G Hultén, Xiang Qin, et al.
JAMA
|
April 5, 2016
Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction: A Randomized Clinical Trial
Michelle L O'Donoghue, Ruchira Glaser, Matthew A Cavender, et al.
Nature Medicine
|
January 31, 2017
DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma
Nathan C Sheffield, Gaelle Pierron, Johanna Klughammer, et al.
Molecular Cancer Therapeutics
|
May 5, 2017
Discovery and Characterization of Novel Nonsubstrate and Substrate NAMPT Inhibitors
Julie L Wilsbacher, Min Cheng, Dong Cheng, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
November 16, 2020
The incidence of venous thromboembolic events in trauma patients after tranexamic acid administration: an EAST multicenter study
Lisbi Rivas, Jordan Estroff, Andrew Sparks, et al.
Journal of Medicinal Chemistry
|
April 4, 2017
Fragment-Based, Structure-Enabled Discovery of Novel Pyridones and Pyridone Macrocycles as Potent Bromodomain and Extra-Terminal Domain (BET) Family Bromodomain Inhibitors
Le Wang, John K Pratt, Todd Soltwedel, et al.
Science Translational Medicine
|
March 20, 2015
Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy
Joel D Leverson, Darren C Phillips, Michael J Mitten, et al.
Page
of 95
Search research articles
Search
Showing results (891-900 of 949) with videos related to
Sort By:
Page
of 95
Nature Communications
|
April 17, 2026
NKG2A inhibition promotes NK cell-CD8<sup>+</sup> T cell interactions to improve anticancer immunity in ovarian carcinoma
Tereza Lanickova, Artemis Angelidou, Michal Hensler, et al.
Nature Communications
|
March 22, 2024
Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer
Lenka Kasikova, Jana Rakova, Michal Hensler, et al.
Molecular Cancer Therapeutics
|
September 5, 2025
Advancing preclinical biology for Ewing Sarcoma: an international effort
Filemon S Dela Cruz, Elizabeth A Stewart, Didier Surdez, et al.
BMC Microbiology
|
November 8, 2007
Subtle genetic changes enhance virulence of methicillin resistant and sensitive Staphylococcus aureus
Sarah K Highlander, Kristina G Hultén, Xiang Qin, et al.
JAMA
|
April 5, 2016
Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction: A Randomized Clinical Trial
Michelle L O'Donoghue, Ruchira Glaser, Matthew A Cavender, et al.
Nature Medicine
|
January 31, 2017
DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma
Nathan C Sheffield, Gaelle Pierron, Johanna Klughammer, et al.
Molecular Cancer Therapeutics
|
May 5, 2017
Discovery and Characterization of Novel Nonsubstrate and Substrate NAMPT Inhibitors
Julie L Wilsbacher, Min Cheng, Dong Cheng, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
November 16, 2020
The incidence of venous thromboembolic events in trauma patients after tranexamic acid administration: an EAST multicenter study
Lisbi Rivas, Jordan Estroff, Andrew Sparks, et al.
Journal of Medicinal Chemistry
|
April 4, 2017
Fragment-Based, Structure-Enabled Discovery of Novel Pyridones and Pyridone Macrocycles as Potent Bromodomain and Extra-Terminal Domain (BET) Family Bromodomain Inhibitors
Le Wang, John K Pratt, Todd Soltwedel, et al.
Science Translational Medicine
|
March 20, 2015
Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy
Joel D Leverson, Darren C Phillips, Michael J Mitten, et al.
Page
of 95